L&C Bio Co., Ltd

KOSDAQ 290650.KQ

L&C Bio Co., Ltd Market Capitalization on January 14, 2025: USD 367.44 M

L&C Bio Co., Ltd Market Capitalization is USD 367.44 M on January 14, 2025, a -21.49% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

L&C Bio Co., Ltd 52-week high Market Capitalization is USD 468.04 M on January 15, 2024, which is 27.38% above the current Market Capitalization.
L&C Bio Co., Ltd 52-week low Market Capitalization is USD 244.90 M on November 14, 2024, which is -33.35% below the current Market Capitalization.
L&C Bio Co., Ltd average Market Capitalization for the last 52 weeks is USD 346.60 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

KOSDAQ: 290650.KQ

L&C Bio Co., Ltd

CEO	Mr. Chul Lee Whan
IPO Date	Nov. 1, 2018
Location	South Korea
Headquarters	Suntechcity
Employees	122
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals Research & Consulting

Description

L&C BIO Co., Ltd. operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam, South Korea.

Key trends

Past 5 years